Using such potent approaches for identifying circulating specific immune signatures of intrathecal ELS activity will open new dimensions in deciphering CXCL13/CXCR5-associated immune activities as drivers of neuroinflammation and possible therapeutic targets with relevance for infection control, chronic inflammation, and CNS autoimmunity. This evidence concerns the gene CXCL13 and infection.